|
⚲
|
| Keyboard |
| NovaQuest Co-Investment Fund XV LP
✚
|
|
|---|---|
| CIK # | 0001949248 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001949248] | |
| 4 | [0001949248] | |
| SC 13D | [0001949248] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| NovaQuest Co-Investment Fund XV LP | Aceragen Inc | [2023-01-18] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Idera Pharmaceuticals Inc | |
| NovaQuest Co-Investment Fund XV LP | |
| NQ POF V GP Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Idera Pharmaceuticals Inc ACGN
Warrant · derivative
|
2023-01-17 | Conversion | 830,294 | ||
|
Idera Pharmaceuticals Inc ACGN
Warrant · derivative
|
2023-01-17 | Conversion | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Series X Preferred Stock
|
2022-09-28 | Other | 5 | ||
|
Idera Pharmaceuticals Inc IDRA
Series Z Preferred Stock · derivative
|
2022-09-28 | Other | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Warrant · derivative
|
2022-09-28 | Other | 14,115 | ||
|
Idera Pharmaceuticals Inc IDRA
Warrant · derivative
|
2022-09-28 | Other | 1,343,547 |